CDSCO

CDSCO Expert Panel recommends emergency use of Covaxin for children aged 2-18

New Delhi: The CDSCO (Central Medicines Standards Control Organization) expert committee has approved the administration of Covaxin to children between the ages of 2 and 18, according to official sources. After a meeting yesterday, the SEC sent its recommendation to the Drug Controller General of India for approval. Phase II and III trials were conducted …

CDSCO Expert Panel recommends emergency use of Covaxin for children aged 2-18 Read More »

Indian Covid-19 Vaccine

Indian Covid-19 Vaccine: Health Ministry Gives Nod To Emergency Use Of Covovax, Corbevax & Molnupiravir Drug

Indian Covid-19 Vaccine: Union Health Minister Mansukh Mandaviya announced on Tuesday that the Central Drugs Standard Control Organization (CDSCO) has approved the COVID-19 vaccine from the Serum Institute of India Covovax, the jab of Biological E Corbevax and the anti-Covid pill Molnupiravir for restricted use in emergencies. The Union Minister of Health announced via Twitter, …

Indian Covid-19 Vaccine: Health Ministry Gives Nod To Emergency Use Of Covovax, Corbevax & Molnupiravir Drug Read More »

Scroll to Top